Related Experiment Video
Updated: Oct 17, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Identification of glucose 6-phosphate dehydrogenase deficiency in a population with a high frequency of thalassemia
A Tagarelli1, A Piro, L Bastone
1Istituto di Medicina Sperimentale e Biotecnologie-CNR, Contrada Burga, 87050, Mangone, Italy. tagare@imseb.cs.cnr.it
Insights
This study examined glucose 6-phosphate dehydrogenase (G6PD) deficiency and thalassemia trait in Calabria. G6PD activity in carriers is more accurately assessed by comparing them to thalassemia trait carriers, not normal subjects.
Area of Science:
- Human Genetics
- Biochemistry
- Population Health
Background:
- High prevalence of thalassemia trait (5.2%) and glucose 6-phosphate dehydrogenase (G6PD) deficiency (1.3% in males) in the Calabrian population.
- Co-occurrence of G6PD deficiency, thalassemia trait, and total iron serum deficiency observed in the study population.
Purpose of the Study:
- To assess G6PD activity in a Calabrian population with high frequencies of genetic anomalies.
- To determine the most reliable method for evaluating G6PD activity in heterozygous individuals, particularly when co-occurring with thalassemia trait or iron deficiency.
Main Methods:
- Differential pH-metry technique used for G6PD activity measurement.
- Analysis of 1239 whole blood samples from Calabrian subjects (age 10-55).
- Categorization of subjects based on the presence of thalassemia trait, G6PD deficiency, iron deficiency, and their combinations.
Main Results:
- G6PD heterozygous subjects' enzymatic activity can be masked by thalassemia trait and total iron serum deficiency.
- Comparison of G6PD activity in heterozygous subjects with thalassemia trait is more reliable when referenced against carriers of the thalassemia trait.
- This comparative method is more accurate than referencing against G6PD activity in normal subjects.
Conclusions:
- The study highlights the complexity of diagnosing G6PD deficiency in populations with co-existing genetic conditions like thalassemia trait.
- A refined comparative approach is recommended for accurate G6PD activity assessment in heterozygous individuals within such populations.
- Findings have implications for genetic screening and clinical management in regions with high carrier frequencies.
Abstract:
High frequencies of both thalassemia trait (5.2%) and glucose 6-phosphate dehydrogenase (G6PD) deficiency for only males (1.3%) have been observed in the Calabrian population. The G6PD activity measurement was carried out on 1239 samples of whole blood from Calabrian subjects of both sexes (age range 10-55) by a differential pH-metry technique which was quite suitable to determine the G6PD deficiency in mass screenings. The analyzed subjects showed: only the thalassemia trait; or only the G6PD deficiency; or only the total iron serum deficiency; or G6PD deficiency associated with the thalassemia trait or with the total iron serum deficiency. The G6PD heterozygous subjects have an enzymatic activity which is masked by both the thalassemia trait and the total iron serum deficiency. In a population showing high frequencies of both thalassemia trait and G6PD deficiency, the comparison of G6PD activity of heterozygous subjects also affected with the thalassemia trait is more reliable if referred to the enzymatic activity of the carriers of the latter inherited anomaly rather than to G6PD activity of normal subjects.
Related Concept Videos
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism
Hyperglycemia
Pedigree Analysis
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Energy-requiring Steps of Glycolysis

